[PDF] Top 20 ADHERENCE, ADVERSE DRUG REACTION AND EFFECTIVENESS OF THE HEPATITIS C CHRONIC TREATMENT
Has 10000 "ADHERENCE, ADVERSE DRUG REACTION AND EFFECTIVENESS OF THE HEPATITIS C CHRONIC TREATMENT" found on our website. Below are the top 20 most common "ADHERENCE, ADVERSE DRUG REACTION AND EFFECTIVENESS OF THE HEPATITIS C CHRONIC TREATMENT".
ADHERENCE, ADVERSE DRUG REACTION AND EFFECTIVENESS OF THE HEPATITIS C CHRONIC TREATMENT
... assess adherence, adverse drug reaction and Sustained Virological Response (SVR) in the therapy for he- patitis ...for hepatitis treatment in Southern ...under ... See full document
8
Hepatitis C in hemodialysis: the contribution of injection drug use
... Background: Hepatitis C virus (HCV) infection is the most common cause of acute or chronic hepatitis in patients on hemodialysis ...(HD). The purpose of this study ... See full document
5
Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil
... after the diagnose of chronic hepatitis C, and assumes three groups of patients: one treated with conventional IFN, another with PegIFN alpha 2b of 12 kD, ... See full document
9
Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil
... using the Student’s t test and frequencies using the chi-square ...evaluate the association between the vari- ables under scrutiny and SVR, logistic regression models were used ... See full document
6
Gender influence on treatment of chronic hepatitis C genotype 1
... weight and less frequent history of alcohol abuse than shown by ...predictor of SVR. Nevertheless, women and men presented equivalent BMI means, similar proportions of high viral load ... See full document
7
Braz. J. Pharm. Sci. vol.52 número4
... outcomes and promotes a reduction in health expenditure. However, treatment duration and lack of eicacy decrease adherence to pharmacotherapy, resulting in increased mortality ... See full document
10
Value in Health
... Poor adherence is a serious issue in the management of patients with chronic hepatitis C (CHC) owing to the difficulty of treatment with pegylated inter- ... See full document
1
Arq. Gastroenterol. vol.47 número3
... injecting drug users might not differ from the general population in terms of sustained virological response when adherent to therapy for chronic hepatitis ...group of patients. ... See full document
4
A hepatitis C virus infection model with time-varying drug effectiveness: solution and analysis.
... characterize the decay phases is only possible given the analytic ...expansions and showed that the long-time decay is dominated by the rate of loss of HCV-infected cells, ... See full document
12
Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease.
... calibration and discrimination. For each model, the calibration was measured using the Hosmer and Lemeshow goodness of fit test ...determines the differences between observed ... See full document
8
Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon
... Clinical and laboratory data and liver biopsies of 174 pa- tients known to have developed SVR after therapy with dif- ferent forms of IFN monotherapy or IFN combined with RBV were eligible for ... See full document
5
Simultaneous detection of hepatitis B virus genotypes and mutations associated with resistance to lamivudine, adefovir, and telbivudine by the polymerase chain reaction-ligase detection reaction
... chronic hepatitis B. Of the 216 patients, 52 were treated with lamivudine alone, 82 were treated with adefovir alone, 51 were treated with lamivudine initially but became re- sistant to ... See full document
7
Ciênc. saúde coletiva vol.16 número12
... Abstract Drug users (DU) are a marginalized group and at risk for viral hepatitis, who seldom access health ...with chronic HBV/HCV and 15 in-depth interviews with health profes- ... See full document
10
Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C
... for the treatment of Hepatitis C based on a financing mod- el and a universal access policy in order to guarantee the treatment of all patients registered ... See full document
6
Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors
... aim of this study was to determine risk factors for adverse events (AE)-related treatment discontinuation and severe anemia among patients with chronic hepatitis C virus ... See full document
9
Geographic distribution of hepatitis C virus genotypes in Brazil
... Reverse and forward strand sequences were aligned and a consensus sequence was obtained for each ...case. The consensus se- quence was then compared with the se- quences of all HCV ... See full document
9
An eye on hepatitis C: a review
... HCV treatment regimen recommended by Brazil’s Ministry of Health involves the use of ...on the HCV genotype/subtype, some regimens still use IFN in its pegylated form ...by the ... See full document
7
Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada.
... serious adverse effects missed in clinical trials and many drugs have been either removed from the market or have seen warnings added to their labels due to post marketing reports of ... See full document
10
Braz. J. Pharm. Sci. vol.48 número2
... hepatite C crônica de acordo com o protocolo brasileiro, tratados com PEG-IFN alfa-2a ou 2b associado a ...(max=57,4% and min=12,8%) e por intenção de tratamento de ... See full document
10
Análise do efeito in vitro de acridonas na replicação do Vírus da Hepatite C
... Hepatite C é a inflamação do fígado causada pela infecção pelo Vírus da hepatite C (HCV – do inglês Hepatitis C ...Hepatite C é um problema amplamente distribuído no mundo, acometendo ... See full document
38
temas relacionados